Hiroki Ishiguro1, Kunio Miyake2, Koichi Tabata1, Chiaki Mochizuki1, Takeshi Sakurai3, Emmanuel S Onaivi4. 1. Department of Neuropsychiatry and Clinical Ethics, University of Yamanashi, Chuo, Japan. 2. Department of Health Sciences, University of Yamanashi, Chuo, Japan. 3. Medical Innovation Center, Kyoto University, Kyoto, Japan. 4. Department of Biology, William Paterson University, Wayne, New Jersey.
Abstract
AIMS: The human NRCAM gene is associated with polysubstance use. Nrcam knockout mice do not acquire a preference for addictive substances. We aimed to elucidate the role of Nrcam in specific neural circuits underlying congenital preference for substances and the acquisition of addiction. METHODS: We analyzed gene expression patterns of neural molecules to find a common addiction pathway dependent on Nrcam function. We examined monoaminergic, glutamatergic, and GABAergic systems in the brains of Nrcam knockout mice following treatment with methamphetamine (METH) or saline (SAL) using micro-array gene expression analysis, which was replicated using TaqMan gene expression analysis. To find a common addiction pathway, we examined similarities and differences between the expression patterns of molecules in METH-treated mice and in Nrcam knockout mice treated with cocaine (COC). RESULTS: Glutaminase expression in brain was reduced in Nrcam heterozygous mice after METH and COC treatment, consistent with our previous study. Metabotropic glutamate receptor 2 expression was reduced in Nrcam heterozygous mice that received either METH or COC treatment. Several other molecules could act in independent addiction pathways involving METH or COC. We also found that GABA receptor subunit g2 expression was reduced in Nrcam heterozygous mice that underwent SAL treatment, and that METH treatment attenuated this reduction. CONCLUSION: Nrcam differentially regulates glutamatergic and GABAergic molecules in naive brains and in brains of animals with acquired addiction. Elucidating the complex neural mechanisms underlying polysubstance use will uncover biological features of addiction and may contribute to the development of effective pharmaceutical treatments.
AIMS: The humanNRCAM gene is associated with polysubstance use. Nrcam knockout mice do not acquire a preference for addictive substances. We aimed to elucidate the role of Nrcam in specific neural circuits underlying congenital preference for substances and the acquisition of addiction. METHODS: We analyzed gene expression patterns of neural molecules to find a common addiction pathway dependent on Nrcam function. We examined monoaminergic, glutamatergic, and GABAergic systems in the brains of Nrcam knockout mice following treatment with methamphetamine (METH) or saline (SAL) using micro-array gene expression analysis, which was replicated using TaqMan gene expression analysis. To find a common addiction pathway, we examined similarities and differences between the expression patterns of molecules in METH-treated mice and in Nrcam knockout mice treated with cocaine (COC). RESULTS:Glutaminase expression in brain was reduced in Nrcam heterozygous mice after METH and COC treatment, consistent with our previous study. Metabotropic glutamate receptor 2 expression was reduced in Nrcam heterozygous mice that received either METH or COC treatment. Several other molecules could act in independent addiction pathways involving METH or COC. We also found that GABA receptor subunit g2 expression was reduced in Nrcam heterozygous mice that underwent SAL treatment, and that METH treatment attenuated this reduction. CONCLUSION:Nrcam differentially regulates glutamatergic and GABAergic molecules in naive brains and in brains of animals with acquired addiction. Elucidating the complex neural mechanisms underlying polysubstance use will uncover biological features of addiction and may contribute to the development of effective pharmaceutical treatments.
Authors: Alina Kurolap; Florian Kreuder; Claudia Gonzaga-Jauregui; Morasha Plesser Duvdevani; Tamar Harel; Luna Tammer; Baozhong Xin; Somayeh Bakhtiari; James Rice; Clare L van Eyk; Jozef Gecz; Jean K Mah; Derek Atkinson; Heidi Cope; Jennifer A Sullivan; Alon M Douek; Daniel Colquhoun; Jason Henry; Donald Wlodkowic; Yesim Parman; Ayşe Candayan; Elif Kocasoy-Orhan; Anat Ilivitzki; Shiri Soudry; Rina Leibu; Fabian Glaser; Valerie Sency; Gil Ast; Vandana Shashi; Michael C Fahey; Esra Battaloğlu; Albena Jordanova; Vardiella Meiner; A Micheil Innes; Heng Wang; Orly Elpeleg; Michael C Kruer; Jan Kaslin; Hagit Baris Feldman Journal: Am J Hum Genet Date: 2022-02-01 Impact factor: 11.043
Authors: Alex Moore; Kavitha Chinnaiya; Dong Won Kim; Sarah Brown; Iain Stewart; Sarah Robins; Georgina K C Dowsett; Charlotte Muir; Marco Travaglio; Jo E Lewis; Fran Ebling; Seth Blackshaw; Andrew Furley; Marysia Placzek Journal: Front Neurosci Date: 2022-04-07 Impact factor: 5.152